Mount Sinai's Icahn School of Medicine is one of the leading academic medical centers in the United States. Its integrative medicine program maintains an herb and supplement database used by practitioners to evaluate the evidence behind complementary therapies — including botanical supplements, mineral compounds, and traditional medicines. When this database documents concerns about a supplement, those concerns carry institutional weight.
People searching “Mount Sinai shilajit” are typically trying to answer a specific question: what does a credible, independent medical institution say about whether this supplement is safe? The answer from Mount Sinai's integrative guidance — consistent with that of NCCIH and Memorial Sloan Kettering — is nuanced in a way that most supplement marketing and most supplement criticism fails to capture.
This article covers what Mount Sinai's herb and supplement documentation indicates about shilajit, where those concerns are most and least applicable, and how their guidance compares to that of the other major US medical institutions that have assessed the same evidence base. For a broader safety overview that covers FDA status, contraindications, and dosing, see our complete shilajit safety guide.
What Mount Sinai's Database Indicates About Shilajit
Mount Sinai's herb and supplement database evaluates supplements across multiple dimensions: available laboratory evidence, preclinical (animal) research, human clinical trials, safety profile, and specific population concerns. Their documentation on shilajit reflects the current state of the science accurately. Here is a factual summary of the core areas their guidance addresses:
Heavy Metal Contamination Risk
Mount Sinai's integrative medicine guidance identifies heavy metal contamination as the primary documented safety concern with shilajit. As a geological mineral pitch, shilajit naturally concentrates metals present in its surrounding rock formations — including lead, mercury, arsenic, and cadmium. Unprocessed or inadequately purified products can contain these metals at levels that exceed established safety thresholds. This concern is real, evidence-based, and product-specific rather than universal.
Limited High-Quality Human Clinical Evidence
The clinical research base for shilajit in humans remains preliminary. Available studies are generally small, short in duration (most under 90 days), and focused on narrow outcome measures. Mount Sinai's guidance accurately characterizes the evidence as insufficient to support firm clinical conclusions for most of the health claims associated with shilajit. Preclinical evidence is more extensive but does not directly translate to human efficacy.
Not FDA Approved
Shilajit is not approved by the FDA as a drug. It is sold in the United States as a dietary supplement under DSHEA (1994), which does not require manufacturers to demonstrate safety or efficacy before market entry. Mount Sinai's guidance notes this regulatory context — it means there is no government pre-market quality review applied to shilajit products before they reach consumers.
Pregnancy and Breastfeeding Caution
Mount Sinai's guidance recommends avoiding shilajit during pregnancy and breastfeeding. No clinical trials have enrolled pregnant women to study shilajit's effects, leaving a complete absence of safety data for this population. Combined with the documented heavy metal risk in unverified products — and the known fetal toxicity of lead and mercury at low doses — avoidance is the appropriate precautionary position.
Potential Medication Interactions
Mount Sinai's database notes that shilajit may interact with certain medications, particularly those affecting coagulation, immune function, or hepatic metabolism. The interaction profile is not fully characterized due to the limited clinical evidence base. Anyone on prescription medications — particularly blood thinners, immunosuppressants, or medications for kidney or liver conditions — should consult a physician before use.
The Key Nuance: Contamination Risk Is Tied to Product Quality, Not the Compound
The most important implication of Mount Sinai's guidance — and the one most frequently missed — is that the heavy metals concern is not a statement about shilajit as a compound. It is a statement about what happens when shilajit is sold without proper purification and independent lab verification.
Raw, unprocessed shilajit from unknown sources presents the risk that Mount Sinai's guidance describes. Purified shilajit with a batch-specific Certificate of Analysis from an accredited US laboratory — showing actual measured heavy metals values below FDA action levels — directly addresses the concern being raised. The same analytical chemistry that makes contamination a documented risk in unverified products is the tool that responsible brands use to confirm their products are clean.
- ✗Products with no COA published on the brand website
- ✗COAs from unaccredited or overseas labs
- ✗No batch number — cannot trace to a specific production run
- ✗Pass/fail summaries without actual measured metal values
- ✗Products sold under private label with undisclosed supply chains
- ✓ISO/IEC 17025 or A2LA-accredited US laboratory
- ✓ICP-MS analytical method for heavy metals detection
- ✓Batch-specific COA with actual measured Pb, Hg, As, Cd values
- ✓Values compared against FDA action levels and Prop 65 thresholds
- ✓Microbiology panel in addition to heavy metals
For a full breakdown of how to read a shilajit COA and what each field means, see our shilajit heavy metals comparison →
How Mount Sinai's Guidance Compares to NCCIH and MSK
Mount Sinai is not alone in its assessment. The three major US medical institutions that have documented shilajit guidance all reach substantively the same conclusions through independent analysis of the same evidence base.
| Concern | Mount Sinai | NCCIH | Memorial Sloan Kettering |
|---|---|---|---|
| Heavy metals | Contamination risk in unverified products | Flags contamination — raw/unprocessed products | Heavy metal contamination documented safety concern |
| Human evidence | Limited — small, short-term trials | Insufficient high-quality trials | Preliminary — most studies small and short-term |
| Pregnancy | Precautionary avoidance — no safety data | Potentially unsafe — insufficient data | Advises avoidance — no clinical data |
| Compound safety | No blanket condemnation of purified product | Concern is product quality, not compound | Flags product quality variation specifically |
| FDA status | Dietary supplement — not FDA approved | Not FDA approved as a drug | Not FDA-approved or regulated for efficacy |
What “Verified” Actually Means in Practice
The verification standard that addresses Mount Sinai's concerns is not proprietary or complicated. It maps directly to four criteria that any consumer can check independently:
Verification checklist for shilajit buyers
ISO/IEC 17025 or A2LA-accredited US laboratory
Accreditation numbers are public record — searchable in the A2LA or ILAC directories. A COA from a named, accredited US lab is the highest available quality assurance for American supplement buyers. Examples: IAS Laboratories (Phoenix, AZ), Certified Laboratories (Burbank, CA — A2LA ISO 17025, Cert 3034.01).
ICP-MS as the specified analytical method
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is the gold standard for detecting lead, mercury, arsenic, and cadmium at parts-per-billion sensitivity. Any COA that specifies ICP-MS methodology provides stronger analytical quality assurance than those using older or less sensitive methods.
Batch-specific COA with a printed batch number
A COA without a batch number cannot be traced to the product you purchased. Batch traceability is fundamental — it connects the lab results to a specific production run, not a hypothetical average of past testing. Look for a batch or lot number printed on both the product packaging and the COA.
Microbiology panel in addition to heavy metals
A comprehensive COA covers more than heavy metals — it also tests for total aerobic count, yeast, mold, and pathogens such as E. coli and Salmonella. Brands with microbiology panels alongside heavy metals testing are demonstrating a more complete quality control commitment.
Lab-Verified Brands That Address These Concerns
The following five brands in our database have batch-specific COAs from named, accredited third-party laboratories. We present this data as a quality reference — not as a medical endorsement, and not as a claim that any product has been evaluated or approved by Mount Sinai, the Icahn School of Medicine, or any other medical institution.
- ✓IAS Laboratories, Phoenix AZ (ISO/IEC 17025 accredited)
- ✓Batch 93, May–Jun 2025 · ICP-MS heavy metals panel
- ✓Mercury: ND (not detected) · All metals within FDA limits
- ✓Fulvic acid: resin 64.51% / tablets 73.11% / capsules 74.30%
- ✓GMP Certified · Non-GMO · Vegan · Made in USA
Affiliate link — commission at no extra cost
- ✓Certified Laboratories, Burbank CA (A2LA ISO 17025, Cert 3034.01)
- ✓Batch BHC4429 / 2024057703, Jul–Aug 2025
- ✓Lead: 0.040 mcg/serving — lowest of any brand in our database
- ✓Fulvic acid: not disclosed on COA
- ✓GMP Certified · NAMA member · AHPA member
Affiliate link — commission at no extra cost
- ✓Certified Laboratories + Micro Quality Labs, Burbank CA (A2LA ISO 17025)
- ✓Most recent COA Sep 2024 · Full ICP-MS heavy metals panel
- ✓Mercury: ND · All metals within FDA limits
- ✓Fulvic acid: ~58%
- ✓Source: Himalayan Mountains, 16,000+ ft
Affiliate link — commission at no extra cost
- ✓DaaneLabs, Naples FL + Harken Research, Los Angeles CA
- ✓Most recent testing Nov 2024 · DBP Verified
- ✓Full heavy metals panel — within FDA limits
- ✓Fulvic acid: not disclosed on COA
- ✓Source: UNESCO-recognized Altai Mountains
Affiliate link — commission at no extra cost
- ✓Purblack Inc., Temecula CA — GMP certified facility
- ✓Most recent COA Dec 2025 · Third-party accredited testing
- ✓Full heavy metals panel — within FDA limits
- ✓DBP content: 16.5–21.9% · Urolithin A: up to 58.497 ppm
- ✓Fulvic acid not reported — uses DBP/Urolithin A as quality markers
Affiliate link — commission at no extra cost
Conclusion: Three Institutions, One Core Message
Mount Sinai, NCCIH, and Memorial Sloan Kettering have each independently assessed the shilajit evidence base and reached the same core conclusions: heavy metals contamination risk is real in unverified products, the human clinical evidence base is limited, and pregnancy avoidance is appropriate given the absence of safety data for that population. These are accurate characterizations of the current science and should not be dismissed.
The practical implication of this institutional convergence is that the question “is shilajit safe?” cannot be answered without specifying which product. The institutional warnings apply with full force to products without accredited lab documentation. For products with batch-specific ICP-MS COAs from named, accredited US laboratories, the primary documented concern — heavy metals contamination — is directly and verifiably addressed.
Healthy adults who are not pregnant, not breastfeeding, and not on interacting medications are in a materially different risk category than the unverified-product scenario that drives institutional caution. Choosing a brand with proper documentation does not eliminate all uncertainty, but it directly addresses the concern that three of the country's leading medical institutions have identified as the most actionable risk in this product category.
64.51% fulvic acid (Batch 93, IAS Labs) · Third-party COA · Cold-processed · Free shipping — S-tier resin at $36.99.
- 64.51% fulvic acid — Batch 93 COA, IAS Laboratories Phoenix AZ
- 161mg fulvic acid per serving (June 2025 COA)
- Heavy metals (ICP-MS): Lead 1.17 ppm · Mercury ND · all within FDA limits
- Microbiology: Listeria ND · Salmonella Absent · E. coli ND
- Cold-process purification preserves bioactive compounds
- Free shipping on all orders
Affiliate link — we earn a small commission at no extra cost to you
Frequently asked questions
What does Mount Sinai say about shilajit?
Mount Sinai's Icahn School of Medicine maintains an herb and supplement database used by integrative medicine practitioners. Their documentation on shilajit reflects a measured, evidence-based position: some preclinical and limited human clinical evidence supports traditional uses, but the evidence base is not considered robust by current clinical standards. Their key safety concerns center on heavy metal contamination risk in unverified products, limited long-term human safety data, and precautionary guidance for pregnant and breastfeeding women. These concerns are consistent with the positions of NCCIH and Memorial Sloan Kettering's integrative medicine database.
Does Mount Sinai recommend shilajit?
Mount Sinai's database does not make blanket supplement endorsements. Their documentation on shilajit neither categorically endorses nor condemns the supplement — it describes what the available evidence shows and flags specific safety concerns. The practical implication of their guidance is that consumers should prioritize product quality verification (specifically heavy metals testing) and avoid use during pregnancy. Their concerns apply most sharply to unverified products without independent lab documentation. ShilajitPrice.com is not affiliated with Mount Sinai, and no shilajit brand reviewed on this site has been endorsed or approved by Mount Sinai or its Icahn School of Medicine.
What heavy metals does Mount Sinai warn about in supplements?
Mount Sinai's integrative medicine guidance, consistent with NCCIH and other major US medical institutions, identifies lead (Pb), mercury (Hg), arsenic (As), and cadmium (Cd) as the primary heavy metal contaminants of concern in mineral-based supplements including shilajit. These four metals occur naturally in geological environments and can concentrate in shilajit at levels that vary significantly based on geographic source and purification method. The standard for verification is an ICP-MS heavy metals panel from an ISO/IEC 17025 or A2LA-accredited third-party laboratory, with actual measured values compared against FDA dietary supplement action levels.
How does Mount Sinai's shilajit guidance compare to NCCIH?
Mount Sinai's guidance and NCCIH's guidance are substantively aligned. Both institutions flag the same three core concerns: heavy metal contamination risk in unverified products, limited high-quality human clinical evidence, and precautionary avoidance during pregnancy and breastfeeding. Neither institution makes a blanket statement that purified, lab-tested shilajit is unsafe for healthy adults — their concerns are specifically tied to product quality verification and population-specific risk factors. Memorial Sloan Kettering's database reaches the same conclusions through the same evidence-based framework.
Which shilajit brands address Mount Sinai's contamination concerns?
Brands that directly address Mount Sinai's heavy metals contamination concern are those with batch-specific Certificates of Analysis from ISO/IEC 17025 or A2LA-accredited third-party laboratories, using ICP-MS methodology, with actual measured values for lead, mercury, arsenic, and cadmium published and below FDA action levels. In our database: Black Lotus Shilajit (IAS Laboratories, Phoenix AZ, Batch 93, Hg ND) and Lotus Blooming Herbs (Certified Laboratories, Burbank CA, A2LA ISO 17025 Cert 3034.01, Batch BHC4429, Pb 0.040 mcg/serving — lowest in our database) represent the strongest documentation. Pure Himalayan (Certified Laboratories + Micro Quality Labs, Sep 2024), Natural Shilajit (DaaneLabs + Harken Research, Nov 2024), and Pürblack (Dec 2025 COA) also have independent third-party testing on file.
Not sure which shilajit is right for you? Take our free 60-second quiz →
Adrian Voss is the founder of ShilajitPrice.com and a trained anthropologist with a focus on Cultural Anthropology and traditional medicine practices across the Carribbean, Central Asia and the Himalayas. He first encountered shilajit through his research studying traditional healing systems and Eastern Religion and has used it personally for over six years. Frustrated by the lack of transparent, data-driven information in the Western supplement market, he built ShilajitPrice.com to bring the same rigorous standards of research he applies in academic work to consumer supplement buying — starting with verified lab data, honest sourcing claims, and real price transparency.